From: Optical coherence tomography in patients with Parkinson’s disease
OCT parameters | Duration of disease (years) | UPDRS scores | HY staging | |||
---|---|---|---|---|---|---|
(r) | p value | (r) | p value | (r) | p value | |
RNFL thickness | ||||||
Superonasal | − 0.221 | 0.232 | − 0.077 | 0.682 | 0.003 | 0.987 |
Inferonasal | − 0.201 | 0.278 | − 0.108 | 0.564 | − 0.028 | 0.879 |
Nasal | − 0.335 | 0.065 | − 0.389 | 0.030* | − 0.250 | 0.175 |
Superior temporal | − 0.308 | 0.092 | − 0.210 | 0.258 | − 0.241 | 0.191 |
Inferior temporal | − 0.319 | 0.080 | − 0.328 | 0.072 | − 0.399 | 0.026 |
Temporal | − 0.259 | 0.160 | − 0.371 | 0.040* | − 0.413 | 0.021* |
Macular measurements | ||||||
Central foveal thickness | − 0.304 | 0.091 | − 0.329 | 0.066 | − 0.441 | 0.011* |
Superior parafoveal thickness | − 0.337 | 0.059 | − 0.219 | 0.228 | − 0.433 | 0.013* |
Inferior parafoveal thickness | − 0.387 | 0.029* | − 0.391 | 0.027* | − 0.605 | < 0.001* |
Nasal parafoveal thickness | − 0.341 | 0.056 | − 0.391 | 0.027* | − 0.649 | < 0.001* |
Temporal parafoveal thickness | − 0.401 | 0.023* | − 0.321 | 0.073 | − 0.544 | 0.001* |
Macular volume | − 0.411 | 0.019* | − 0.458 | 0.008* | − 0.545 | 0.001* |
GCC thickness | ||||||
Average | − 0.403 | 0.022* | − 0.484 | 0.005* | − 0.511 | 0.003* |
Superior | − 0.421 | 0.017* | − 0.476 | 0.006* | − 0.482 | 0.005* |
Inferior | − 0.358 | 0.044* | − 0.460 | 0.008* | − 0.515 | 0.003* |